Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil.

Aschele C, Debernardis D, Bandelloni R, Cascinu S, Catalano V, Giordani P, Barni S, Turci D, Drudi G, Lonardi S, Gallo L, Maley F, Monfardini S.

Ann Oncol. 2002 Dec;13(12):1882-92.

PMID:
12453856
2.

Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.

Benson AB 3rd.

Oncology (Williston Park). 1998 Oct;12(10 Suppl 7):28-34. Review.

3.

[Recent advance in chemotherapy for advanced colorectal cancer].

Aiba K.

Gan To Kagaku Ryoho. 1996 Apr;23(5):535-48. Review. Japanese.

PMID:
8678510
4.

Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer.

Grem JL.

Oncology (Williston Park). 2001 Jan;15(1 Suppl 2):13-9. Review.

5.

[5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma].

Baur M, Schlappack O, Havelec L, Mader R, Marosi C, Scheithauer W, Dittrich C.

Wien Klin Wochenschr. 1991;103(11):332-9. Review. German.

PMID:
1858384
6.

Biomodulation of Fluorouracil in colorectal cancer.

Ardalan B, Luis R, Jaime M, Franceschi D.

Cancer Invest. 1998;16(4):237-51. Review.

PMID:
9589033
7.

Critical factors for optimizing the 5-fluorouracil-folinic acid association in cancer chemotherapy.

Etienne MC, Guillot T, Milano G.

Ann Oncol. 1996 Mar;7(3):283-9. Review.

PMID:
8740793
8.

Preclinical and clinical aspects of biomodulation of 5-fluorouracil.

Sotos GA, Grogan L, Allegra CJ.

Cancer Treat Rev. 1994 Jan;20(1):11-49. Review.

PMID:
7507404
9.

Recent advances in the treatment of advanced colorectal cancer.

Kemeny N, Lokich JJ, Anderson N, Ahlgren JD.

Cancer. 1993 Jan 1;71(1):9-18. Review.

PMID:
8416731
10.

[Biochemical modulation of 5-FU with interferon].

Akazawa S.

Gan To Kagaku Ryoho. 1992 Jul;19(7):963-9. Review. Japanese.

PMID:
1626952
11.

Role of leucovorin dosing and administration schedule.

Jolivet J.

Eur J Cancer. 1995 Jul-Aug;31A(7-8):1311-5. Review.

PMID:
7577042
12.

[Chemotherapy of colorectal cancers with metastases].

de Gramont A, Louvet C, André T, Tournigand C, Raymond E, Krulik M.

Presse Med. 1996 Nov 16;25(35):1678-82. Review. French.

PMID:
8977579
13.

Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review.

Formentini A, Henne-Bruns D, Kornmann M.

Langenbecks Arch Surg. 2004 Oct;389(5):405-13. Epub 2004 Aug 12. Review.

PMID:
15309542
14.

Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies.

Labianca R, Pessi A, Facendola G, Pirovano M, Luporini G.

Eur J Cancer. 1996;32A Suppl 5:S7-12. Review.

PMID:
8958036
15.

The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.

Köhne CH, Wilke H, Schöffski P, Schmoll HJ.

J Infus Chemother. 1996 Fall;6(4):206-10. Review. No abstract available.

PMID:
9229317
16.

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.

Sobrero AF, Aschele C, Bertino JR.

J Clin Oncol. 1997 Jan;15(1):368-81. Review.

PMID:
8996164
17.

[5-fluorouracil and colorectal tumors: use in clinical practice and the "MISURA" project].

Labianca R, Poletti P.

Tumori. 1998 Nov-Dec;84(6 Suppl 2):S10-2. Review. Italian.

PMID:
10083888
18.

Management of hepatic metastases from colorectal cancer: systemic chemotherapy.

Leyland-Jones B, Burdette-Radoux S.

J Gastrointest Surg. 1997 Nov-Dec;1(6):576-82. Review.

PMID:
9834394
19.

Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?

Showalter SL, Showalter TN, Witkiewicz A, Havens R, Kennedy EP, Hucl T, Kern SE, Yeo CJ, Brody JR.

Cancer Biol Ther. 2008 Jul;7(7):986-94. Epub 2008 Apr 21. Review.

20.

Prognostic factors in human colorectal cancer.

Bianco AR, Carlomagno C, De Laurentiis M, De Placido S, Tortora G, Ciardiello F.

Tumori. 1997 Jan-Feb;83(1 Suppl):S15-8. Review. No abstract available.

PMID:
9154061

Supplemental Content

Support Center